Observational Study of the Prognosis in Treated Arterial Hypertension

This study has been completed.
Sponsor:
Information provided by:
Odense University Hospital
ClinicalTrials.gov Identifier:
NCT00225030
First received: September 13, 2005
Last updated: NA
Last verified: July 2004
History: No changes posted
  Purpose

Observational study of life time prognosis for persons medically treated for arterial hypertension, according to current WHO-guidelines.


Condition Intervention
Hypertension
Drug: antihypertensive drugs according to current guidelines

Study Type: Observational
Study Design: Observational Model: Natural History
Time Perspective: Longitudinal
Official Title: Observational Study of the Prognosis in Treated Arterial Hypertension

Resource links provided by NLM:


Further study details as provided by Odense University Hospital:

Estimated Enrollment: 1000
Study Start Date: January 1970
Estimated Study Completion Date: July 2004
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

hypertension according to WHO-defined criteria

Exclusion Criteria:

age < 18 years

pregnancy

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00225030

Locations
Denmark
Medicial Dept. C, Odense University Hospital
Odense, Denmark, DK-5000
Sponsors and Collaborators
Odense University Hospital
Investigators
Principal Investigator: Michael Strate, MD
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00225030     History of Changes
Other Study ID Numbers: SHAP-DK
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: Denmark: National Board of Health

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases
Antihypertensive Agents
Cardiovascular Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 15, 2014